Hic-5 inhibitors are a class of chemical compounds that specifically target and inhibit Hic-5 (Hydrogen peroxide-inducible clone-5), a scaffolding protein that belongs to the paxillin family. Hic-5, also known as TGFB1I1 (TGF-beta 1-induced transcript 1), is primarily involved in the regulation of cellular processes such as cell adhesion, migration, and the response to mechanical stress. It localizes to focal adhesions, which are complexes that connect the extracellular matrix to the actin cytoskeleton, facilitating communication between the cell's external environment and its internal signaling pathways. Hic-5 acts as a molecular scaffold, interacting with various signaling proteins to regulate cytoskeletal dynamics and cell motility. Inhibiting Hic-5 interferes with these protein-protein interactions, thereby disrupting the signaling pathways it mediates.
Chemically, Hic-5 inhibitors are designed to interact with domains of the protein responsible for binding to its partners, such as the LIM domains or the focal adhesion targeting (FAT) domain. These inhibitors may prevent Hic-5 from interacting with other key proteins involved in focal adhesion assembly or alter its conformation, leading to impaired function in cellular signaling. The development of Hic-5 inhibitors involves structure-activity relationship (SAR) studies and computational modeling to identify compounds that selectively block its scaffolding functions without affecting related proteins like paxillin. By inhibiting Hic-5, researchers can explore its role in cellular mechanics, adhesion dynamics, and responses to external stimuli. These inhibitors provide critical tools for dissecting the complex signaling networks that govern cell structure and movement, as well as the broader regulatory functions Hic-5 performs in maintaining cellular architecture.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
An anti-allergic drug that can modulate TGF-β signaling, potentially affecting Hic-5 activity. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
An anti-fibrotic agent known to inhibit TGF-β, indirectly impacting Hic-5-related pathways in fibrosis. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $89.00 $275.00 | 9 | |
A TGF-β receptor kinase inhibitor, indirectly affects Hic-5 activity via the TGF-β signaling pathway. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Another TGF-β receptor kinase inhibitor, can modulate Hic-5 activity indirectly by targeting TGF-β signaling. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
A potent inhibitor of TGF-β receptor I and II, potentially affects Hic-5 in TGF-β-related pathways. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $88.00 | 3 | |
A TGF-βR1 kinase inhibitor, can indirectly influence Hic-5 function in TGF-β-mediated processes. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
An inhibitor of TGF-β type I receptor ALK5 kinase, potentially influencing Hic-5 indirectly. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
An inhibitor of collagen type I synthesis and TGF-β signaling, might indirectly affect Hic-5's role in fibrosis. | ||||||